Browse All

Current Filters

CLEAR FILTER x

TITLE

Beyond Clinical Trials: Cenobamate’s Effectiveness in Diverse Epilepsy Populations

Author:Lin, Shenney   Fornari Caprara, Ana Leticia   Pitton Rissardo, Jamir   Pivonka, April   Piotrowski, Kaitlyn   Elgendy, Omnea   Petruncio, Matthew   Burakgazi-Dalkilic, Evren   

Session Name:P3: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Mechanisms and Pharmacology  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P3.007  

Author Institution:Cooper Medical School of Rowan University, NJ  Cooper University Hospital, NJ  

Pimavanserin for Parkinson’s Disease Psychosis: A Meta-analysis of Placebo-controlled Randomized Trials

Author:Petruncio, Matthew George   Pitton Rissardo, Jamir   Elmandouh, Omar   Fornari Caprara, Ana Leticia   Walker, Ian M.   

Session Name:P3: Movement Disorders: Parkinson's Disease Management 1  

Topic:Movement Disorders  

Program Number:P3.013  

Author Institution:Cooper Medical School of Rowan University, NJ  Cooper University Hospital, Camden, NJ  Cooper University Hospital, NJ  

Diagnostic Delays in Meningitis and Encephalitis: Are all Patients Treated Equally?

Author:Lee Yu, Melody Hope   Bhalgat, Ishan Jitendra   Hanretty, Alexandra   Kludjiian, Geena   Nikolic, Dejan   Foppiano Palacios, Carlo   

Session Name:P5: Infectious Disease: Meningoencephalitis  

Topic:Infectious Disease  

Program Number:P5.005  

Author Institution:Cooper University Hospital, NJ  Cooper Medical School of Rowan University, NJ  

Acute Increases in PM2.5 Associated with Higher Stroke Severity and Large-Artery Atherosclerosis in Camden, New Jersey

Author:Garfinkel, Lucas   Jaffri, Zehra   Qureshi, Humza   Piotrowski, Kaitlyn   Anand, Anjela   Debski, Nicole   Penckofer, Mary   Jovin, Maria   Abidin, Zain   Christman, Zachary   Hanafy, Khalid   Cerceo, Elizabeth   

Session Name:P6: Cerebrovascular Disease and Interventional Neurology: Acute Stroke Management and Interventional Techniques 2  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P6.011  

Author Institution:Cooper Medical School of Rowan University, Philadelphia, PA  Rowan-Virtua School of Osteopathic Medicine, NJ  Cooper Medical School of Rowan University, NJ  Rowan University, NJ  Cooper Medical School of Rowan University, Clementon, NJ  Cooper University Health Care, NJ  

Do SGLT2 Inhibitors Influence Parkinson’s Disease Risk? A Meta-analysis of Randomized Trials

Author:Alexander, Theres Boby   Pitton Rissardo, Jamir   Fornari Caprara, Ana Leticia   Walker, Ian M.   

Session Name:P6: Movement Disorders: Parkinson's Disease Emerging Therapeutics 1  

Topic:Movement Disorders  

Program Number:P6.012  

Author Institution:Cooper Medical School of Rowan University, NJ  Cooper University Hospital, Camden, NJ  Cooper University Hospital, NJ